Cargando…
Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
Loss of the maternal UBE3A allele causes Angelman syndrome (AS), a debilitating neurodevelopmental disorder. Here, we devised an AS treatment strategy based on reinstating dual-isoform expression of human UBE3A (hUBE3A) in the developing brain. Kozak sequence engineering of our codon-optimized vecto...
Autores principales: | Judson, Matthew C., Shyng, Charles, Simon, Jeremy M., Davis, Courtney R., Punt, A. Mattijs, Salmon, Mirabel T., Miller, Noah W., Ritola, Kimberly D., Elgersma, Ype, Amaral, David G., Gray, Steven J., Philpot, Benjamin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564914/ https://www.ncbi.nlm.nih.gov/pubmed/34676830 http://dx.doi.org/10.1172/jci.insight.144712 |
Ejemplares similares
-
Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes
por: Sonzogni, Monica, et al.
Publicado: (2019) -
Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations
por: Bossuyt, Stijn N V, et al.
Publicado: (2021) -
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
por: Elgersma, Ype, et al.
Publicado: (2021) -
The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome
por: Viho, Eva M. G., et al.
Publicado: (2022) -
Molecular and behavioral consequences of Ube3a gene overdosage in mice
por: Punt, A. Mattijs, et al.
Publicado: (2022)